E-LIB Suche - Ergebnisse für: Lescarbeau, André

1

Discovery of lirafugratinib (RLY-4008), a highly selective ..:

Schönherr, Heike ; Ayaz, Pelin ; Taylor, Alexander M....
Proceedings of the National Academy of Sciences. 121 (2024) 6 - p. , 2024

Link: https://doi.org/10.1073/..

2

Identification of GDC-1971 (RLY-1971), a SHP2 Inhibitor Des..:

Taylor, Alexander M. ; Williams, Bret R. ; Giordanetto, Fabrizio...
Journal of Medicinal Chemistry. 66 (2023) 19 - p. 13384-13399 , 2023

Link: https://doi.org/10.1021/..

3

Discovery and Clinical Proof-of-Concept of RLY-2608, a Firs..:

Varkaris, Andreas ; Pazolli, Ermira ; Gunaydin, Hakan...
Cancer Discovery. 14 (2023) 2 - p. 240-257 , 2023

Link: https://doi.org/10.1158/..

4

Development of a Multi Kilogram-Scale, Tandem Cyclopropanat..:

Austad, Brian C. ; Hague, Andrew B. ; White, Priscilla...
Organic Process Research & Development. 20 (2016) 4 - p. 786-798 , 2016

Link: https://doi.org/10.1021/..

5

Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ..:

Evans, Catherine A. ; Liu, Tao ; Lescarbeau, André...
ACS Medicinal Chemistry Letters. 7 (2016) 9 - p. 862-867 , 2016

Link: https://doi.org/10.1021/..

6

A Design of Experiments Approach to a Robust Final Deprotec..:

Martinot, Theodore A. ; Austad, Brian C. ; Côté, Alexandre...
Organic Process Research & Development. 19 (2015) 11 - p. 1693-1702 , 2015

Link: https://doi.org/10.1021/..

7

Synthetic Silvestrol Analogues as Potent and Selective Prot..:

Liu, Tao ; Nair, Somarajan J. ; Lescarbeau, André...
Journal of Medicinal Chemistry. 55 (2012) 20 - p. 8859-8878 , 2012

Link: https://doi.org/10.1021/..

8

Discovery of a Potent and Orally Active Hedgehog Pathway An..:

Tremblay, Martin R. ; Lescarbeau, André ; Grogan, Michael J....
Journal of Medicinal Chemistry. 52 (2009) 14 - p. 4400-4418 , 2009

Link: https://doi.org/10.1021/..

9

Discovery of a Selective Phosphoinositide-3-Kinase (PI3K)-γ..:

Evans, Catherine A ; Liu, Tao ; Lescarbeau, André...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018865/. , 2016

Link: http://www.ncbi.nlm.nih...

10

Table S3 from Discovery and Clinical Proof-of-Concept of RL..:

Andreas Varkaris ; Ermira Pazolli ; Hakan Gunaydin...
doi:10.1158/2159-8290.25183922.v1. , 2024

Link: https://doi.org/10.1158/..

11

Table S1 from Discovery and Clinical Proof-of-Concept of RL..:

Andreas Varkaris ; Ermira Pazolli ; Hakan Gunaydin...
doi:10.1158/2159-8290.25183931.v1. , 2024

Link: https://doi.org/10.1158/..

12

Figure S4 from Discovery and Clinical Proof-of-Concept of R..:

Andreas Varkaris ; Ermira Pazolli ; Hakan Gunaydin...
doi:10.1158/2159-8290.25183949.v1. , 2024

Link: https://doi.org/10.1158/..

13

Table S2 from Discovery and Clinical Proof-of-Concept of RL..:

Andreas Varkaris ; Ermira Pazolli ; Hakan Gunaydin...
doi:10.1158/2159-8290.25183925.v1. , 2024

Link: https://doi.org/10.1158/..

14

Figure S2 from Discovery and Clinical Proof-of-Concept of R..:

Andreas Varkaris ; Ermira Pazolli ; Hakan Gunaydin...
doi:10.1158/2159-8290.25183955.v1. , 2024

Link: https://doi.org/10.1158/..

15

Figure S4 from Discovery and Clinical Proof-of-Concept of R..:

Andreas Varkaris ; Ermira Pazolli ; Hakan Gunaydin...
doi:10.1158/2159-8290.25191474.v1. , 2024

Link: https://doi.org/10.1158/..